应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MIRA Mira Pharma
盘后交易 07-18 18:20:51 EDT
0.7860
-0.0341
-4.16%
盘后
0.7999
+0.0139
+1.77%
17:10 EDT
最高
0.8890
最低
0.7600
成交量
33.31万
今开
0.8378
昨收
0.8201
日振幅
15.73%
总市值
1,162万
流通市值
712.78万
总股本
1,478万
成交额
27.42万
换手率
3.67%
流通股本
906.84万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Mira Pharma
所属市场:
NASDAQ
上市日期:
--
主营业务:
MIRA Pharmaceuticals, Inc.于2020年9月在佛罗里达州成立。该公司是一家处于临床开发阶段的生物制药公司,正在开发其候选产品MIRA1a,作为一种合成大麻素类似物,通过靶向大麻素1型和2型(CB1和CB2)受体来治疗焦虑和慢性疼痛。该公司致力于开发和商业化一种新的分子合成THC类似物,目前正在研究中,通常用于治疗与早期痴呆相关的焦虑和认知能力下降的成人患者。该公司的候选药物MIRA1a如果获得FDA的批准,可能会在治疗神经精神、炎症和神经系统疾病和紊乱方面取得重大进展。
发行价格:
--
{"stockData":{"symbol":"MIRA","market":"US","secType":"STK","nameCN":"Mira Pharma","latestPrice":0.786,"timestamp":1721332800000,"preClose":0.8201,"halted":0,"volume":333098,"hourTrading":{"tag":"盘后","latestPrice":0.7999,"preClose":0.786,"latestTime":"17:10 EDT","volume":891,"amount":714.1857722999999,"timestamp":1721337019463},"delay":0,"floatShares":9068414,"shares":14780885,"eps":-0.648584,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.0341,"latestTime":"07-18 18:20:51 EDT","open":0.8378,"high":0.889,"low":0.76,"amount":274165.8854675,"amplitude":0.157298,"askPrice":0.81,"askSize":135,"bidPrice":0.7184,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.648584,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721347200000},"adr":0,"listingDate":1691035200000,"adjPreClose":0.8201,"preHourTrading":{"tag":"盘前","latestPrice":0.8299,"preClose":0.8201,"latestTime":"09:23 EDT","volume":9151,"amount":7497.07333374,"timestamp":1721309032170},"postHourTrading":{"tag":"盘后","latestPrice":0.7999,"preClose":0.786,"latestTime":"17:10 EDT","volume":891,"amount":714.1857722999999,"timestamp":1721337019463},"volumeRatio":0.051143},"requestUrl":"/m/hq/s/MIRA","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.mirapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.466},{"period":"1month","weight":0.139},{"period":"3month","weight":-0.0214},{"period":"6month","weight":-0.0124},{"period":"1year","weight":-0.8828},{"period":"ytd","weight":-0.219}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.018},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.2262},{"period":"ytd","weight":0.1717}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MIRA Pharmaceuticals, Inc.于2020年9月在佛罗里达州成立。该公司是一家处于临床开发阶段的生物制药公司,正在开发其候选产品MIRA1a,作为一种合成大麻素类似物,通过靶向大麻素1型和2型(CB1和CB2)受体来治疗焦虑和慢性疼痛。该公司致力于开发和商业化一种新的分子合成THC类似物,目前正在研究中,通常用于治疗与早期痴呆相关的焦虑和认知能力下降的成人患者。该公司的候选药物MIRA1a如果获得FDA的批准,可能会在治疗神经精神、炎症和神经系统疾病和紊乱方面取得重大进展。","exchange":"NASDAQ","name":"Mira Pharma","nameEN":"Mira Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mira Pharma(MIRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mira Pharma(MIRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mira Pharma,MIRA,Mira Pharma股票,Mira Pharma股票老虎,Mira Pharma股票老虎国际,Mira Pharma行情,Mira Pharma股票行情,Mira Pharma股价,Mira Pharma股市,Mira Pharma股票价格,Mira Pharma股票交易,Mira Pharma股票购买,Mira Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mira Pharma(MIRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mira Pharma(MIRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}